Follow the 알피바이오 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 알피바이오 has published 1 reports. Market capitalisation: €47.8bn. The latest transaction was filed on 16 March 2026 (Other). Among the most active insiders: 알피바이오. All data is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.